Drug intelligence / Profile preview

CFX Tandem

Development stage: Preclinical
Lead developer: Cellular Logistics
Modality: Hydrogel Systems → Drug Delivery Systems, iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration: Epicardial, Intracardiac

Overview

CFX Tandem is a preclinical-stage regenerative medicine therapy developed by Cellular Logistics for the treatment of chronic heart failure. It utilizes the company's Tandem platform, which combines CFX (Cardiac Fibroblast matriX)—a cell-free therapeutic biomaterial derived from cardiac fibroblasts using induced pluripotent stem cell (iPSC) technology—with therapeutic stem cells. This combination is designed to work synergistically to remuscularize scarred myocardium and restore cardiac function. The mechanism of action involves activating endogenous repair mechanisms, promoting angiogenesis, and modulating inflammatory responses in damaged heart tissue. The therapy can be administered as injectable particulates via catheter or as a patch for local epicardial delivery.

Other names: CFX (Cardiac Fibroblast matriX) + Stem cellsTandem platform

Beyond the preview

Go deeper on CFX Tandem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CFX Tandem.

Explore the full profile